Multiplex Mutation Screening by Mass Spectrometry-Reference-Cited by-同舟云学术

Multiplex Mutation Screening by Mass Spectrometry

Published:2011-09 Issue:5 Volume:13 Page:504-513
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Beadling Carol,Heinrich Michael C.,Warrick Andrea,Forbes Erin M.,Nelson Dylan,Justusson Emily,Levine Judith,Neff Tanaya L.,Patterson Janice,Presnell Ajia,McKinley Arin,Winter Laura J.,Dewey Christie,Harlow Amy,Barney Oscar,Druker Brian J.,Schuff Kathryn G.,Corless Christopher L.

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference65 articles.

1. Translation of the Philadelphia chromosome into therapy for CML;Druker;Blood,2008

2. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor;Heinrich;J Clin Oncol,2003

3. Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group

4. Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials;Jackman;Clin Cancer Res,2009

5. Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer;Sartore-Bianchi;PLoS One,2009

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CanSeer: A Method for Development and Clinical Translation of Personalized Cancer Therapeutics;2022-07-02

2. Target Enrichment Enhances the Sensitivity of Sanger Sequencing for BRAF V600 Mutation Detection;2021-08-15

3. Prevalence of class I–III BRAF mutations among 114,662 cancer patients in a large genomic database;Experimental Biology and Medicine;2020-10-05

4. Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples;Journal of Translational Medicine;2020-02-22

5. Skin;Oncological Surgical Pathology;2020